{"id":"https://openalex.org/W2605404264","doi":"https://doi.org/10.1038/srep46347","title":"Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties","display_name":"Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties","alternate_titles":[],"publication_year":2017,"publication_date":"2017-04-11","ids":{"openalex":"https://openalex.org/W2605404264","doi":"https://doi.org/10.1038/srep46347","mag":"2605404264","pmid":"https://pubmed.ncbi.nlm.nih.gov/28397880","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5387714"},"language":"en","primary_location":{"id":"doi:10.1038/srep46347","doi":"https://doi.org/10.1038/srep46347","is_oa":true,"landing_page_url":"https://doi.org/10.1038/srep46347","pdf_url":"https://www.nature.com/articles/srep46347.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2605404264"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/srep46347.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024637740","display_name":"Cheng Luo","orcid":"https://orcid.org/0000-0003-3864-8382","observed_orcids":["https://orcid.org/0000-0003-3864-8382"]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cheng Luo","raw_affiliation_strings":["Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China","institution_ids":["https://openalex.org/I161716053"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Song Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Song Chen","raw_affiliation_strings":["Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China","institution_ids":["https://openalex.org/I161716053"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Na Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Na Xu","raw_affiliation_strings":["Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China","institution_ids":["https://openalex.org/I161716053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083833865","display_name":"Chi Chiu Wang","orcid":"https://orcid.org/0000-0002-3928-7278","observed_orcids":["https://orcid.org/0000-0002-3928-7278"]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chi Wang","raw_affiliation_strings":["Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China","institution_ids":["https://openalex.org/I161716053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068914620","display_name":"Wenbo Sai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wen bo Sai","raw_affiliation_strings":["Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China","institution_ids":["https://openalex.org/I161716053"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wei Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wei Zhao","raw_affiliation_strings":["Jiangsu Chia Tai Tianqing Pharmaceutical Co, Ltd, Nanjing, 210023, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Chia Tai Tianqing Pharmaceutical Co, Ltd, Nanjing, 210023, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102647679","display_name":"Ying Chun Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ying chun Li","raw_affiliation_strings":["Jiangsu Chia Tai Tianqing Pharmaceutical Co, Ltd, Nanjing, 210023, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Chia Tai Tianqing Pharmaceutical Co, Ltd, Nanjing, 210023, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xiao jing Hu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiao jing Hu","raw_affiliation_strings":["Jiangsu Chia Tai Tianqing Pharmaceutical Co, Ltd, Nanjing, 210023, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Chia Tai Tianqing Pharmaceutical Co, Ltd, Nanjing, 210023, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104012253","display_name":"Hong Tian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hong Tian","raw_affiliation_strings":["Jiangsu Chia Tai Tianqing Pharmaceutical Co, Ltd, Nanjing, 210023, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Chia Tai Tianqing Pharmaceutical Co, Ltd, Nanjing, 210023, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105470775","display_name":"Xiang dong Gao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Xiang dong Gao","raw_affiliation_strings":["Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China","institution_ids":["https://openalex.org/I161716053"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009146376","display_name":"Wen Bing Yao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Wen bing Yao","raw_affiliation_strings":["Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China","institution_ids":["https://openalex.org/I161716053"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5009146376","https://openalex.org/A5105470775"],"corresponding_institution_ids":["https://openalex.org/I161716053"],"apc_list":{"value":2690,"currency":"USD","value_usd":2690},"apc_paid":{"value":2690,"currency":"USD","value_usd":2690},"fwci":1.9499,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.85095639,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"7","issue":"1","first_page":"46347","last_page":"46347"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5863999724388123,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5863999724388123,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.3483999967575073,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11663","display_name":"Viral Infectious Diseases and Gene Expression in Insects","score":0.01850000023841858,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/glycoengineering","display_name":"glycoengineering","score":0.8840000033378601},{"id":"https://openalex.org/keywords/antibody-glycosylation","display_name":"antibody glycosylation","score":0.9419999718666077},{"id":"https://openalex.org/keywords/fucose","display_name":"fucose","score":0.9150000214576721},{"id":"https://openalex.org/keywords/sialic-acid","display_name":"sialic acid","score":0.9980000257492065},{"id":"https://openalex.org/keywords/desialylation","display_name":"desialylation","score":0.8460000157356262},{"id":"https://openalex.org/keywords/neuraminidase","display_name":"neuraminidase","score":0.7990000247955322},{"id":"https://openalex.org/keywords/fcgammariiia","display_name":"Fc\u03b3RIIIa","score":0.8270000219345093},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9929999709129333},{"id":"https://openalex.org/keywords/complement-dependent-cytotoxicity","display_name":"complement-dependent cytotoxicity","score":0.9990000128746033},{"id":"https://openalex.org/keywords/asialoglycoprotein-receptor","display_name":"asialoglycoprotein receptor","score":0.8500000238418579},{"id":"https://openalex.org/keywords/hepatic-clearance","display_name":"hepatic clearance","score":0.8970000147819519},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8259999752044678},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9909999966621399},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8610000014305115},{"id":"https://openalex.org/keywords/asialofetuin","display_name":"asialofetuin","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.8986295461654663},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.8579519987106323},{"id":"https://openalex.org/C2780115458","wikidata":"https://www.wikidata.org/wiki/Q419311","display_name":"Sialic acid","level":2,"score":0.645163357257843},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5744213461875916},{"id":"https://openalex.org/C2776841590","wikidata":"https://www.wikidata.org/wiki/Q66589589","display_name":"Fucose","level":3,"score":0.5499826669692993},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5419171452522278},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5040404200553894},{"id":"https://openalex.org/C2777313579","wikidata":"https://www.wikidata.org/wiki/Q898365","display_name":"Glycosylation","level":2,"score":0.4926453232765198},{"id":"https://openalex.org/C11569505","wikidata":"https://www.wikidata.org/wiki/Q727265","display_name":"Asialoglycoprotein receptor","level":4,"score":0.485462486743927},{"id":"https://openalex.org/C73695083","wikidata":"https://www.wikidata.org/wiki/Q409485","display_name":"Sialidase","level":4,"score":0.46526291966438293},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42276573181152344},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.3471890389919281},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.256591260433197},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.22686076164245605},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.18028956651687622},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.17851462960243225},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16842523217201233},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.11447614431381226},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.09494885802268982},{"id":"https://openalex.org/C134164806","wikidata":"https://www.wikidata.org/wiki/Q409485","display_name":"Neuraminidase","level":3,"score":0.06583523750305176},{"id":"https://openalex.org/C2776200302","wikidata":"https://www.wikidata.org/wiki/Q827450","display_name":"Hepatocyte","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006031","descriptor_name":"Glycosylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011499","descriptor_name":"Protein Processing, Post-Translational","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015202","descriptor_name":"Protein Engineering","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1038/srep46347","doi":"https://doi.org/10.1038/srep46347","is_oa":true,"landing_page_url":"https://doi.org/10.1038/srep46347","pdf_url":"https://www.nature.com/articles/srep46347.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5387714","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5387714/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Rep","raw_type":"Text"},{"id":"pmid:28397880","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28397880","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific reports","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/srep46347","doi":"https://doi.org/10.1038/srep46347","is_oa":true,"landing_page_url":"https://doi.org/10.1038/srep46347","pdf_url":"https://www.nature.com/articles/srep46347.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1321655441","display_name":"\u57fa\u4e8e\u4f53\u5916\u4ee3\u8c22\u7279\u5f81\u7684\u86cb\u767d\u8d28\u7c7b\u836f\u7269\u65e9\u671f\u6210\u836f\u6027\u8bc4\u4ef7\u4f53\u7cfb\u7814\u7a76","funder_award_id":"81430082","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G3243893974","display_name":null,"funder_award_id":"2015XPT02","funder_id":"https://openalex.org/F4320335787","funder_display_name":"Fundamental Research Funds for the Central Universities"},{"id":"https://openalex.org/G7558401484","display_name":null,"funder_award_id":"81430082","funder_id":"https://openalex.org/F4320327518","funder_display_name":"Priority Academic Program Development of Jiangsu Higher Education Institutions"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320321605","display_name":"Government of Jiangsu Province","ror":"https://ror.org/004svx814"},{"id":"https://openalex.org/F4320327518","display_name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","ror":null},{"id":"https://openalex.org/F4320335787","display_name":"Fundamental Research Funds for the Central Universities","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2605404264.pdf","grobid_xml":"https://content.openalex.org/works/W2605404264.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W83569430","https://openalex.org/W628257392","https://openalex.org/W1191527629","https://openalex.org/W1498130958","https://openalex.org/W1585764350","https://openalex.org/W1963761475","https://openalex.org/W1965205681","https://openalex.org/W1976499917","https://openalex.org/W1979208227","https://openalex.org/W1986197388","https://openalex.org/W2003199416","https://openalex.org/W2023831371","https://openalex.org/W2027577085","https://openalex.org/W2032709270","https://openalex.org/W2040142253","https://openalex.org/W2044791218","https://openalex.org/W2050060618","https://openalex.org/W2052491267","https://openalex.org/W2056769186","https://openalex.org/W2056839334","https://openalex.org/W2057390178","https://openalex.org/W2061837874","https://openalex.org/W2065419141","https://openalex.org/W2065960941","https://openalex.org/W2067367025","https://openalex.org/W2069942860","https://openalex.org/W2084136419","https://openalex.org/W2085594474","https://openalex.org/W2091887204","https://openalex.org/W2094049231","https://openalex.org/W2094932058","https://openalex.org/W2103735104","https://openalex.org/W2106339174","https://openalex.org/W2120661754","https://openalex.org/W2124847934","https://openalex.org/W2125446991","https://openalex.org/W2130005269","https://openalex.org/W2139135964","https://openalex.org/W2144962365","https://openalex.org/W2153565541","https://openalex.org/W2155819450","https://openalex.org/W2158188986","https://openalex.org/W2168072557","https://openalex.org/W2168507982","https://openalex.org/W2170552969","https://openalex.org/W2175128997","https://openalex.org/W2220495680","https://openalex.org/W2259869327","https://openalex.org/W2294765885","https://openalex.org/W2572882118","https://openalex.org/W4294605288"],"related_works":["https://openalex.org/W3040485073","https://openalex.org/W2890074788","https://openalex.org/W3206495503","https://openalex.org/W2596270747","https://openalex.org/W2325475319","https://openalex.org/W3190505322","https://openalex.org/W7153982205","https://openalex.org/W2143869160","https://openalex.org/W2610837173","https://openalex.org/W2044791218"],"abstract_inverted_index":{"Pertuzumab":[0],"is":[1],"an":[2],"antihuman":[3],"HER2":[4,8],"antibody":[5,20],"developed":[6],"for":[7,19,110,182],"positive":[9],"breast":[10],"cancer.":[11],"Glycosylation":[12],"profiles":[13,31],"are":[14],"always":[15],"the":[16,27,33,48,56,66,78,115,127,171,175,190],"important":[17],"issue":[18],"based":[21],"therapy.":[22],"Previous":[23],"findings":[24],"have":[25],"suggested":[26],"impact":[28],"of":[29,35,50,58,68,83,123,132,160,177,189,192,194],"glycosylation":[30],"on":[32,77],"function":[34,57],"antibodies,":[36],"like":[37],"pharmacodynamics,":[38],"antibody-dependent":[39],"cellular":[40],"cytotoxicity":[41,45],"(ADCC)":[42],"and":[43,52,80,95,119,129,179,184],"complement-dependent":[44],"(CDC).":[46],"However,":[47],"roles":[49],"fucose":[51,107,178],"sialic":[53,69,124,137,180],"acid":[54,70,125,181],"in":[55,71,92,143,149,152],"therapeutic":[59,195],"antibodies":[60],"still":[61],"need":[62],"further":[63,187],"investigation,":[64],"especially":[65],"role":[67],"nonfucosylated":[72,88],"antibodies.":[73],"This":[74],"study":[75,173],"focused":[76],"pharmacokinetic":[79,155],"pharmacodynamic":[81],"properties":[82],"pertuzumab":[84,89,97,118,165],"after":[85],"glycoengineering.":[86],"Herein,":[87],"was":[90,98,108],"produced":[91],"CHOFUT8\u2212/\u2212":[93],"cells,":[94],"desialylated":[96,164],"generated":[99],"by":[100,113],"enzymatic":[101],"hydrolysis.":[102],"Present":[103],"data":[104],"indicated":[105],"that":[106,158],"critical":[109],"ADCC":[111,128],"activity":[112,131],"influencing":[114],"interaction":[116],"between":[117],"Fc\u03b3RIIIa,":[120],"nevertheless":[121],"removal":[122],"increased":[126],"CDC":[130],"pertuzumab.":[133],"Meanwhile,":[134],"regarding":[135],"to":[136],"acid,":[138],"sialidase":[139],"hydrolysis":[140],"directly":[141],"resulted":[142],"asialoglycoprotein":[144],"receptors":[145],"(ASGPRs)":[146],"dependent":[147],"clearance":[148],"hepatic":[150],"cells":[151],"vitro.":[153],"The":[154],"assay":[156],"revealed":[157],"co-injection":[159],"asialofetuin":[161],"can":[162],"protect":[163],"against":[166],"ASGPRs-mediated":[167],"clearance.":[168],"Taken":[169],"together,":[170],"present":[172],"elucidated":[174],"importance":[176],"pertuzumab,":[183],"also":[185],"provided":[186],"understanding":[188],"relationship":[191],"glycosylation/pharmacokinetics/pharmacodynamics":[193],"antibody.":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2605404264","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-04-28T00:00:00"}
